28
Participants
Start Date
December 31, 2006
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Ortho Tri-Cyclen LO
Tablets, oral, OTC Lo 1 tab/daily (no dosage units), once daily, 28 days.
Ortho Cyclen
Tablet, oral, Ortho Cyclen 1 tab/daily (no dosage units), once daily, 28 days.
Ortho Cyclen + Efavirenz
Tablet, oral, OC + EFV 600 mg, once daily, 14 days.
Ortho Cyclen
Tablet, oral, OC 1 tab daily (no dosage units), once daily, 7 days.
Covance Clinical Research Unit San Diego, San Diego
Northwest Kinetics, Tacoma
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY